Patients seeking information about nuclear medicine and molecular imaging can now access discoverMI.org, a patient-focused website launched by the Society of Nuclear Medicine (SNM).
The Center for Translational Molecular Medicine, an Eindhoven, Netherlands-based institute for research in molecular techniques for the early diagnosis and treatment of cardiovascular disease and cancer, has launched a new EUR16 million ($21.26 million) project, called TraIT (Translational research IT).
The National Institutes of Health (NIH) Clinical Center has begun imaging patients on a whole-body simultaneous PET and MRI device (Siemens Healthcare, Biograph mMR) as a new weapon in its arsenal to diagnose and treat traumatic brain injury and post-traumatic stress disorder among military service members and civilians.
Written by Kaitlyn Dmyterko
DENVER—Coronary CT Angiography (CCTA) is not indicated for use in atrial fibrillation (AF) patents due to the problems it causes in terms of diagnostic accuracy, Thomas C. Gerber, MD, PhD, of the division of cardiovascular diseases at the Mayo Clinic, Jacksonville, Fla., said during a presentation Sept. 10 at the annual scientific sessions of the American Society of Nuclear Cardiology (ASNC). However, cardiac CT may be beneficial in some instances for this patient population when the right methods are used.
McMaster University in Hamilton, Ontario, has unveiled its newly expanded Nuclear Research Building, which includes a new cyclotron facility and improvements to the McMaster Nuclear Reactor (MNR) Building.
Noninvasive cardiovascular (CV) imaging showed no benefit of improving primary prevention measures for patients; however, the authors wrote that future studies will be necessary to provide hard evidence on how these imaging tests impact prevention efforts, according to a meta-analysis published June 13 in the Archives of Internal Medicine.
Researchers at Purdue University have developed a new type of imaging technology which could be used to take 3D images of plaque lining arteries, according to study findings scheduled to be published June 17 in Physical Review Letters. The authors said the technology could be used to diagnose cardiovascular disease and other “lipid-related disorders,” by measuring ultrasound signals from chemical bonds in molecules exposed to a pulsing laser.
Biotech company ImaginAb has locked a research deal with GE Healthcare to develop PET diagnostic imaging agents for cardiovascular disease, the companies said on June 5.
Written by Justine Cadet
The SNM 2011 annual meeting, being held at the San Antonio Convention, Sports & Entertainment Facilities Center in San Antonio from June 4 to 8, is bridging the ‘ologies, as nuclear medicine and molecular imaging are beginning to stretch their legs into multiple subspecialties, including neurology, cardiology, psychology, pharmacology and oncology—all of which are well represented in the program.
Written by C.P. Kaiser
SPECT myocardial perfusion imaging (MPI) is a well-validated noninvasive test to determine if coronary artery disease (CAD) is the cause of a patient’s chest pain. While SPECT will continue to play a role in this patient population, other tests are helping to fill in the gaps in identifying those at risk of cardiac events.
|
|
|
|
RSS 
